534 related articles for article (PubMed ID: 32997182)
1. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
[TBL] [Abstract][Full Text] [Related]
2. Strategies for Reducing False-Positive Screening Results for Intermediate-Size Nodules Evaluated Using Lung-RADS: A Secondary Analysis of National Lung Screening Trial Data.
Hammer MM; Hunsaker AR
AJR Am J Roentgenol; 2022 Sep; 219(3):397-405. PubMed ID: 35319912
[No Abstract] [Full Text] [Related]
3. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
[TBL] [Abstract][Full Text] [Related]
4. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
5. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
[TBL] [Abstract][Full Text] [Related]
6. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
[TBL] [Abstract][Full Text] [Related]
7. Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals.
Landy R; Wang VL; Baldwin DR; Pinsky PF; Cheung LC; Castle PE; Skarzynski M; Robbins HA; Katki HA
JAMA Netw Open; 2023 Mar; 6(3):e233273. PubMed ID: 36929398
[TBL] [Abstract][Full Text] [Related]
8. Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study.
Tremblay A; Taghizadeh N; MacGregor JH; Armstrong G; Bristow MS; Guo LLQ; Lydell C; Pereira R; Lee A; Elliot T; MacEachern P; Graham A; Dickinson JA; Koetzler R; Lam SC; Yang H; Bédard EL; Tammemagi M; Burrowes P
J Am Coll Radiol; 2019 Oct; 16(10):1425-1432. PubMed ID: 31103442
[TBL] [Abstract][Full Text] [Related]
9. Interobserver variability in Lung CT Screening Reporting and Data System categorisation in subsolid nodule-enriched lung cancer screening CTs.
Yoon SH; Kim YJ; Doh K; Kim J; Lee KH; Lee KW; Kim J
Eur Radiol; 2021 Sep; 31(9):7184-7191. PubMed ID: 33733688
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds.
Meier-Schroers M; Homsi R; Gieseke J; Schild HH; Thomas D
Eur Radiol; 2019 Feb; 29(2):898-905. PubMed ID: 29992387
[TBL] [Abstract][Full Text] [Related]
11. Assisted versus Manual Interpretation of Low-Dose CT Scans for Lung Cancer Screening: Impact on Lung-RADS Agreement.
Jacobs C; Schreuder A; van Riel SJ; Scholten ET; Wittenberg R; Wille MMW; de Hoop B; Sprengers R; Mets OM; Geurts B; Prokop M; Schaefer-Prokop C; van Ginneken B
Radiol Imaging Cancer; 2021 Sep; 3(5):e200160. PubMed ID: 34559005
[TBL] [Abstract][Full Text] [Related]
12. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
[TBL] [Abstract][Full Text] [Related]
13. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.
Silvestri GA; Goldman L; Tanner NT; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Fedewa S
Chest; 2023 Jul; 164(1):241-251. PubMed ID: 36773935
[TBL] [Abstract][Full Text] [Related]
14. Observer variability for Lung-RADS categorisation of lung cancer screening CTs: impact on patient management.
van Riel SJ; Jacobs C; Scholten ET; Wittenberg R; Winkler Wille MM; de Hoop B; Sprengers R; Mets OM; Geurts B; Prokop M; Schaefer-Prokop C; van Ginneken B
Eur Radiol; 2019 Feb; 29(2):924-931. PubMed ID: 30066248
[TBL] [Abstract][Full Text] [Related]
15. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three software systems for semi-automatic volumetry of pulmonary nodules on baseline and follow-up CT examinations.
Zhao YR; van Ooijen PM; Dorrius MD; Heuvelmans M; de Bock GH; Vliegenthart R; Oudkerk M
Acta Radiol; 2014 Jul; 55(6):691-8. PubMed ID: 24132766
[TBL] [Abstract][Full Text] [Related]
17. Lung Cancer Screening with Low-Dose CT in Female Never Smokers: Retrospective Cohort Study with Long-term National Data Follow-up.
Kim HY; Jung KW; Lim KY; Lee SH; Jun JK; Kim J; Hwangbo B; Lee JS
Cancer Res Treat; 2018 Jul; 50(3):748-756. PubMed ID: 28724283
[TBL] [Abstract][Full Text] [Related]
18. Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial.
Kastner J; Hossain R; Jeudy J; Dako F; Mehta V; Dalal S; Dharaiya E; White C
Radiology; 2021 Jul; 300(1):199-206. PubMed ID: 33944631
[TBL] [Abstract][Full Text] [Related]
19. LDCT lung cancer screening in populations at different risk for lung cancer.
Teles GBDS; Macedo ACS; Chate RC; Valente VAT; Funari MBG; Szarf G
BMJ Open Respir Res; 2020 Feb; 7(1):. PubMed ID: 33371010
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
